telehealth.helpFind my match

Home Weight loss (GLP-1) By state Nevada

Nevada GLP-1s: Diabetes First, Then Cash: 8 programs ship to NV

In Nevada, both big public plans ask the same question before paying for a GLP-1: do you have diabetes? If the answer is no, Medicaid and the state employee plan won't cover it. Here is what each plan says, and how Nevadans who want one for weight loss get it at a fair price. The lowest price we found from a program that ships to Nevada: compounded semaglutide at $89 a month on a 12-month plan ($99 month to month) at Lttl.

  • Updated
  • Prices read Nov 12, 2026

Nevada at a glance

Nevada Medicaid
Does not cover for weight loss
State employee plan
Does not cover for weight loss
Adults with obesity
34.2% (2024)
Programs we compare that ship to NV
8 of 22

Online GLP-1 programs for Nevada, cheapest first

Programs that ship to Nevada. Prescribed online by a licensed clinician; medication and delivery included.

How we pick and check programs

Our pick for November 2026

Daily oral plan
Intro offer: from $7 a day

A daily oral GLP-1 plan. No needles, no injections

GLP-1 protocol from$199/moon the 3-month plan with the $100 welcome credit ($299 without), shipped monthly; the home page names no form for this plan (the oral offer is from $7 a day)
Visit HumeCare Read our HumeCare review

Compounded semaglutide in Nevada: lowest monthly price

#ProgramLowest priceMonth to monthLink
1LttlCheapest$89/mo 12-month plan$99 / 4 wksVisitLttl
2BetterMe Rx$99/mo 12-month plan$199/moVisitBetterMe Rx
3Refills$99/mo $99 / 4 wksVisitRefills
4Direct Meds$297/mo $297/moVisitDirect Meds
5GalaFrom $69/mo starting price, plan length not statedNot statedVisitGala
6TrimRxFrom $349/mo starting price, plan length not statedNot statedVisitTrimRx

Compounded tirzepatide in Nevada: lowest monthly price

#ProgramLowest priceMonth to monthLink
1MaximusCheapest$99.99/mo 12-month planNot offeredVisitMaximus
2Lttl$139/mo 12-month plan$149 / 4 wksVisitLttl
3BetterMe Rx$159/mo 12-month plan$249/moVisitBetterMe Rx
4Refills$159/mo $159 / 4 wksVisitRefills
5Direct Meds$399/mo $399/moVisitDirect Meds
6GalaFrom $99/mo starting price, plan length not statedNot statedVisitGala
7TrimRxFrom $279/mo starting price, plan length not statedNot statedVisitTrimRx
  1. Low month-to-month#1
    Up to $140 off your first month

    Compounded semaglutide for $99, month to month

    Semaglutide$99/momonth to month (4-week supply); $89 on a 12-month plan
    Visit Lttl Read our Lttl review
  2. Pills or shots#2
    Semaglutide from $99/mo

    Choose weekly shots or daily tablets; shots from $99/mo on the 12-month plan

    Semaglutide shots from$99/moon the 12-month plan; $199 month to month
    Visit BetterMe Rx Read our BetterMe Rx review
  3. No contract#3
    Fall sale: 40% off

    Compounded semaglutide as low as $99 a month

    Semaglutide as low as$99/moper 4-week supply, month to month; shown during a 40% fall sale
    4.2 on Trustpilot1,779 reviews ·
    Visit Refills Read our Refills review
  4. Low-cost tirzepatide#4
    Same price at every dose

    Compounded tirzepatide from $99.99 a month

    Tirzepatide from$99.99/moon the 12-month plan, paid up front; $199.99 on 2 months
    4.4 on Trustpilot1,106 reviews ·
    Visit Maximus Read our Maximus review
  5. Delivery in 1-2 days#5
    Fall sale: $150 off

    Same price at every dose, at your door in 1-2 days

    Semaglutide$297/momonth to month: medication, doctor visits and shipping included; tirzepatide $399; fall sale: "starting at $147", "$150 off"
    4.5 on Trustpilot17,724 reviews ·
    Visit Direct Meds Read our Direct Meds review

3 more programs are in the price tables above.

Nevada's public plans want a diabetes diagnosis

Nevada Medicaid and Nevada Check Up cover GLP-1s for type 2 diabetes with prior authorization. Drugs used for weight loss are not covered, and KFF lists Nevada among the states with no Medicaid GLP-1 coverage for obesity in January 2026. The one exception is narrow and tied to heart disease, covered below. So a Medicaid member in Las Vegas or Reno who wants Wegovy or Zepbound for weight loss alone pays cash.

The Public Employees' Benefits Program works the same way. At its May 2026 board meeting, PEBP discussed weight management and said GLP-1 coverage requires a diabetes diagnosis from the prescriber. Prediabetes does not count. Weight loss alone does not count. Private plans vary by employer. If you work for a large private employer or have a union health fund, ask your plan directly, since rules differ from plan to plan.

The cash route is easy here. Online programs licensed in Nevada handle the visit online and ship to your door. Maximus ships to Nevada and sells Wegovy and Foundayo tablets as well as compounded tirzepatide. Some compounded semaglutide and tirzepatide programs below hold one price at every dose. You can start this way while you wait to hear back from your insurer.

  • Nevada Medicaid does not cover GLP-1s for obesity (KFF, January 2026). (kff.org)
  • PEBP's May 21, 2026 board meeting transcript says GLP-1 coverage requires a diabetes diagnosis, not prediabetes or weight loss. (pebp.nv.gov)
  • 34.2% of Nevada adults had obesity in 2024, the latest year CDC reports for the state. (cdc.gov)
  • Nevada Medicaid added coverage of Wegovy in April 2024 for reducing major cardiovascular events in recipients who meet prior authorization criteria in line with the FDA label. (medicaid.nv.gov)
  • Effective June 2, 2025, Nevada Medicaid's Wegovy criteria require established cardiovascular disease verified by a specialist who has provided documentation. (medicaid.nv.gov)
  • SB244 (2025) would have required Nevada Medicaid to cover obesity treatment and at least one FDA-approved anti-obesity drug; it died in a money committee. AB399, on bariatric surgery coverage, died in committee. (thenevadaindependent.com)
  • Nevada's adult obesity rate rose more than 3 percentage points to 34.2% in 2024, the largest increase of any state, per a Trust for America's Health analysis of CDC data (not statistically significant). (thenevadaindependent.com)
  • 52.0% of Nevada's Medicare beneficiaries were in Medicare Advantage in 2025 (RUPRI analysis of CMS data). (rupri.public-health.uiowa.edu)
  • CDC's 2025 adult obesity data list Nevada as insufficient data, along with California and Mississippi. (cdc.gov)
  • About 13.6% of Nevada adults had diagnosed diabetes in 2024 (U.S. 12.5%); KFF shows no 2025 figure for Nevada. (kff.org)
  • Medicare.gov says the Medicare GLP-1 Bridge, from July 1, 2026, is open to people with Part D coverage, including Medicare Advantage plans with drug coverage, for a $50 monthly copayment. (medicare.gov)

The heart-disease exception in Nevada Medicaid's Wegovy rules

Since April 2024, Nevada Medicaid has covered Wegovy for one purpose: lowering the risk of major heart events in adults who already have heart or blood vessel disease, such as a past heart attack, a past stroke or symptomatic peripheral artery disease. The state's announcement said it would follow the FDA label, and the criteria require a specialist to prescribe or consult.

The rules tightened in 2025. A change effective June 2, 2025 requires the heart disease to be verified by a specialist who provides documentation. If you have no heart history, this route does not apply, and weight loss alone is still a cash purchase in Nevada.

Carson City's 2025 session: SB244 and AB399 both stalled

Lawmakers tried twice in 2025. SB244, from Sen. Roberta Lange of Las Vegas, would have required Nevada Medicaid to cover intensive behavioral treatment for obesity and at least one FDA-approved anti-obesity medication. It died in a money committee. AB399, from Assemblymember Rebecca Edgeworth, would have required insurers to cover bariatric surgery for people with morbid obesity and lowered the minimum age to 18. It died in committee.

The pressure has not gone away. A Trust for America's Health analysis of CDC data found that Nevada's adult obesity rate rose more than 3 points to 34.2% in 2024, the biggest jump of any state, though the change was not statistically significant. The Legislature meets in odd-numbered years, so 2027 is the next regular session where a coverage bill could return.

Nevada's missing 2025 number and its Medicare Advantage majority

CDC's 2025 adult obesity table lists Nevada as "insufficient data", one of just three states, with California and Mississippi, that have no 2025 figure. That leaves 2024's 34.2% as the latest number. KFF's diabetes table has the same 2025 gap; for 2024 it shows about 13.6% of Nevada adults with diagnosed diabetes, above the national 12.5%.

Medicare Advantage is the larger half of Medicare here. In March 2025, 52.0% of Nevada's Medicare beneficiaries were in an Advantage plan, and 54.1% in its metro counties, according to a University of Iowa RUPRI brief built on CMS data. Medicare.gov lists Advantage plans with drug coverage among those that can use the GLP-1 Bridge, which opened July 1, 2026. An eligible Nevadan pays $50 for a month of Wegovy, Foundayo or the Zepbound KwikPen, and the prescriber sends the prescription and any prior authorization. People with type 2 diabetes, moderate-to-severe sleep apnea or fatty liver disease are left out, since their Part D plan may cover the drug instead.

GLP-1 in Nevada: questions

Does Nevada Medicaid cover Wegovy for weight loss?

No. Nevada Medicaid and Nevada Check Up cover GLP-1s for type 2 diabetes with prior authorization, but drugs used for weight loss are not covered. Members who want a GLP-1 for weight loss usually pay cash through an online program. The programs on this page are confirmed to serve Nevada.

Does PEBP cover GLP-1s for Nevada public employees?

Only with a diabetes diagnosis. PEBP's May 2026 board discussion confirmed the prescriber must attest to type 2 diabetes. Prediabetes and weight loss alone do not qualify. Public employees who want a GLP-1 for weight loss can compare the cash programs below.

Can I get a GLP-1 visit online outside normal hours in Las Vegas?

Often, yes. Many programs let you fill out the medical intake online at any time. The clinician must be licensed in Nevada. If approved, the medication ships to your home, so you don't need to get to a pharmacy between shifts.

What does tirzepatide cost in Reno without insurance?

Compounded tirzepatide from online programs costs less than the brand, and in November 2026 Maximus listed it from $99.99 a month on a 12-month plan. Brand Zepbound, which Maximus also sells, starts at a higher price. The price is the same in Reno, Las Vegas or Elko, since everything ships by mail.

Are GLP-1 pills sold in Nevada?

Yes. The Wegovy pill and the Foundayo pill are FDA-approved for weight loss, and Maximus sells both to Nevada buyers after an online visit. Several compounded programs, such as BetterMe Rx and TrimRx, also offer oral options. Pills are taken daily, while most shots are weekly, so pick the routine you will stick with.

Does Nevada Medicaid ever cover Wegovy?

Yes, in one case. Since April 2024 it covers Wegovy to lower the risk of heart attack and stroke in adults with established heart or blood vessel disease, verified by a specialist. Wegovy for weight loss alone is not covered.

Did Nevada pass a law on obesity drug coverage in 2025?

No. SB244 would have required Nevada Medicaid to cover obesity treatment and at least one FDA-approved anti-obesity drug, but it died in a money committee. A separate bill on bariatric surgery coverage, AB399, also died. The Legislature next meets in regular session in 2027.

See programs for Nevada All states

Sources: kff.org · cdc.gov · pebp.nv.gov